Table 2. Baseline characteristics of the study population by FADS1 genotype.
| FADS1 rs174546 | ||||
|---|---|---|---|---|
| CC | CT | TT | ||
| All | n (%) | 266 (51.2) | 206 (39.6) | 48 (9.2) |
| Sex, n (%) | Girls | 118 (45.4) | 115 (44.2) | 27 (10.4) |
| Boys | 148 (56.9) | 91 (35.0) | 21 (8.1) | |
| Age, years | Mean (SD) | 6.45 (1.67) | 6.52 (1.65) | 6.13 (1.77) |
| 2-<6 years, n (%) | 89 (50.3) | 68 (38.4) | 20 (11.3) | |
| 6-<10 years, n (%) | 177 (51.6) | 138 (40.2) | 28 (8.2) | |
| BMI, Mean (SD)[1] | z-score | 0.95 (1.29) | 0.82 (1.24) | 0.73 (1.26) |
| BP, Mean (SD) | SBP, z-score | 0.35 (0.76) | 0.47 (0.81) | 0.44 (0.71) |
| DBP, z-score | 0.62 (0.59) | 0.63 (0.58) | 0.71 (0.60) | |
| PUFA, % wt/wt, Mean (SD) | 18:2n-6, LA | 17.5 (1.86) | 18.2 (2.13) | 18.5 (1.89) |
| 20:3n-6, DGLA | 1.16 (0.23) | 1.25 (0.22) | 1.43 (0.33) | |
| 20:4n-6, ARA | 7.81 (1.33) | 7.34 (1.34) | 6.88 (1.06) | |
| 18:3n-3, ALA | 0.19 (0.07) | 0.21 (0.09) | 0.21 (0.10) | |
| 20:5n-3, EPA | 0.27 (0.11) | 0.26 (0.11) | 0.25 (0.09) | |
| 22:6n-3, DHA | 1.22 (0.45) | 1.18 (0.45) | 1.13 (0.40) | |
| D5D index, Mean (SD) | 20:4n-6/20:3n-6 | 6.86 (1.18) | 5.94 (1.08) | 4.98 (1.11) |
[1]Cole & Lobstein 2012